NCT07308886 2026-04-13Recombinant Glycosylated Human Interleukin-7 (CYT107) for the Treatment of Kaposi Sarcoma in Participants With HIV and Immune Non-Response (REGIMENKS HIV)National Institutes of Health Clinical Center (CC)Phase 2 Recruiting55 enrolled